- Home
- ECOR vs SCWO Comparison
ECOR vs SCWO Comparison
Compare ECOR & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- SCWO
- Stock Information
- Founded
- ECOR 2005
- SCWO 2021
- Country
- ECOR United States
- SCWO United States
- Employees
- ECOR N/A
- SCWO N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SCWO Environmental Services
- Sector
- ECOR Health Care
- SCWO Utilities
- Exchange
- ECOR Nasdaq
- SCWO Nasdaq
- Market Cap
- ECOR 57.5M
- SCWO 64.3M
- IPO Year
- ECOR 2018
- SCWO N/A
- Fundamental
- Price
- ECOR $6.69
- SCWO $0.34
- Analyst Decision
- ECOR Strong Buy
- SCWO
- Analyst Count
- ECOR 2
- SCWO 0
- Target Price
- ECOR $25.50
- SCWO N/A
- AVG Volume (30 Days)
- ECOR 216.5K
- SCWO 300.8K
- Earning Date
- ECOR 03-12-2025
- SCWO 03-27-2025
- Dividend Yield
- ECOR N/A
- SCWO N/A
- EPS Growth
- ECOR N/A
- SCWO N/A
- EPS
- ECOR N/A
- SCWO N/A
- Revenue
- ECOR $25,182,000.00
- SCWO $445,445.00
- Revenue This Year
- ECOR $40.88
- SCWO $5,945.19
- Revenue Next Year
- ECOR $48.01
- SCWO $106.82
- P/E Ratio
- ECOR N/A
- SCWO N/A
- Revenue Growth
- ECOR 57.09
- SCWO N/A
- 52 Week Low
- ECOR $5.32
- SCWO $0.30
- 52 Week High
- ECOR $19.49
- SCWO $1.99
- Technical
- Relative Strength Index (RSI)
- ECOR 19.00
- SCWO 43.06
- Support Level
- ECOR $6.57
- SCWO $0.33
- Resistance Level
- ECOR $8.25
- SCWO $0.43
- Average True Range (ATR)
- ECOR 0.92
- SCWO 0.03
- MACD
- ECOR -0.15
- SCWO 0.01
- Stochastic Oscillator
- ECOR 4.82
- SCWO 13.46
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.